What You Should Know:
- KLAS asked 16 prominent members of the healthcare community with broad HIT expertise to read 42 KLAS reports on emerging technology and rate their perception of the solutions based on their potential to impact the Quadruple Aim of Healthcare: to improve outcomes, reduce the cost of care, improve the patient experience, and improve the clinician experience.
- The new report by KLAS (1) ranks these emerging solutions by their ability to disrupt the
Read More
Amazon | AWS | Healthcare Innovation | News, Analysis, Insights - HIT Consultant
Why Health Systems Need a New Transition Strategy to APMs
There is an adage that change in healthcare moves at the speed of tectonic plates. The slow adoption of Alternative Payment Models (APMs), the central feature of value-based care, is a good example of constraint despite immense pressure to control costs.
Data from 2020 demonstrate almost zero change from 2018 in the proportion of straight Fee-for-Service (FFS) reimbursement. Other results show a slight uptick in APMs with or without downside risk at 34.6 percent. However,
Read More
Health-Tech C2Q:22 Preview: 5 Key Driving Factors to Watch
What You Should Know:
- David Larsen, healthcare IT and digital health analyst at BTIG published a note highlighting his preview for health-tech Q2 earnings.
- Given high inflation rates, costs for traveling nurses, and light volumes in 2Q:22, he is cautious on stocks that sell into the acute care market in the near term.
An Overview
According to the report, there are many macro headwinds that continue to affect the HCIT sector and the broader market, including inflationary pricing
Read More
Astellas Pharma Selects Verizon to Transform Global Network
What You Should Know:
- Verizon Business has announced that it has been selected to build and manage Astellas Pharma Inc’s (Astellas) global network infrastructure.
- Today’s announcement builds on the company’s network-as-a-service foundation and supports its private networks, mobile edge compute and business solutions vectors of growth.
The Japanese multinational pharma company, one of the 30 biggest pharmaceutical companies in the world by revenue in 2022, is looking to
Read More
Healthcare Companies on the Stock Market
Good healthcare and the financial sector cannot be separated entirely, even when their base motivations lie in different directions. While the medical sector should focus more on the health of the patients instead of consumerism, a good amount of capital is needed to ensure a functional system.
Naturally, we can find healthcare companies on the stock market. Considering the continuous need for health care, that is not tied to market crashes the way other stocks are, this is a great chance for
Read More
CVS Health in Talks to Acquire Signify Health
What You Should Know:
- Signify Health is exploring strategic alternatives including a sale, according to a Wall Street Journal report. Initial bids are due this coming week. Additional companies are also in acquisition discussions with Signfiy Health, and CVS could face competition from other managed-care providers and private-equity firms.
- The potential Signify acquisition has a market value of around $4.7 B after its shares rose on the news of a potential sale.
Leveraging
Read More
Velatura Services Selected for Amazon Web Services Health Equity Initiative
What You Should Know:
- Velatura Services (Velatura) today announced that it has been selected as part of the Amazon Web Services (AWS) Health Equity Initiative, a $40M, three-year commitment supporting organizations that are developing solutions to advance health equity.
- Participation in the initiative will enhance Velatura’s efforts to provide essential data management infrastructure, advance data exchange, improve well-being, and reduce disparities.
Amazon Web
Read More
Digital Pharmacies 2022: Disruptors or Just Another Delivery Channel?
New Insider Intelligence report highlights the current state of digital pharmacies in 2022 along with the challenges and digital opportunities for online pharmacies to appeal to consumers.
With cost and convenience at the forefront of consumer spending decisions and US prescription drug spending continuing to rise through 2026 to an estimated $730.50 billion, winners will offer consumers more robust online resources including pricing transparency, discounts, generic options and more
Read More
How Medical Researchers Can Leverage Tech to Help Streamline Biospecimen Matchmaking and Procurement
Many medical advancements – from life-saving vaccines and treatments to new diagnostic tests like liquid biopsies – are built on research that involves human biospecimens. Biofluids, tissue and cells are indispensable resources for the medical researcher, yet the process of sourcing these biospecimens can be woefully frustrating and inefficient. These challenges can have a direct, negative impact on the pace of discovery, creating urgency for improved access to the biospecimens researchers need
Read More
Analysis: 2022 Semi-Annual Health IT Market Review
Executive Summary
Act III of COVID: Navigating the Crosscurrents of Post-Inflation
2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
